Concepedia

Yoshiaki Washio

YW

Statistics

Publications

12

Citations

760

H-Index

12

Active since

1992

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (Japan)

Molecular Discovery (United Kingdom)

GlaxoSmithKline (Ireland)

Yoshiaki Washio is an author at GlaxoSmithKline (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1992–2020

12

Publications

12

Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors

Masaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio et al. · Journal of Medicinal Chemistry · 2007 · 217 citations · Full text

, , +17

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease

Kenneth Down, Augustin Amour, Angela M. Deakin et al. · Journal of Medicinal Chemistry · 2015 · 132 citations

, , +17

Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site

Jingsong Yang, Nino Campobasso, Mangatt P. Biju et al. · Chemistry & Biology · 2011 · 116 citations

, , +9

DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors

Wieslaw M. Kazmierski, Bing Xia, John F. Miller et al. · Journal of Medicinal Chemistry · 2020 · 63 citations · Full text

, , +16

The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS Hits

Sophie M. Bertrand, Nicolas Ancellin, Benjamin Beaufils et al. · Journal of Medicinal Chemistry · 2015 · 43 citations · Full text

, , +16

1–5 of 12